Blood Coagulation Disorders: Clinical Trials

261 trials for Blood Coagulation Disorders, newest first

ClinicalTrials Daily · Areas · Conditions · Drugs · Sponsors ·

261 completed. 261 Phase 3, 22 Phase 2.

By phase and status

Phase	Trials	Status
Phase 3	261	Completed 261
Phase 2	22	Completed 22

Follow Blood Coagulation Disorders: new trials by email Literature Review of Blood Coagulation Disorders trials Research Report on Blood Coagulation Disorders

Trials (filtered) newest first · largest first

All 261 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Recombinant Single-chain Factor VIII (rVIII-SingleChain) in Chinese Participants With Hemophilia A Previously Treated With FVIII Products Recombinant single-chain factor VIII (rVIII-SingleChain) - Congenital Hemophilia A	Phase 3	Completed	CSL Behring	62	2025-01-09	2026-10-23
Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Chinese Subjects With Hemophilia B Previously Treated With FIX Therapy Recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) - Hemophilia B	Phase 3	Completed	CSL Behring	23	2024-07-28	2026-07-23
Phase 3 Clinical Project of Pegylated Recombinant Human Coagulation Factor VIII-Fc Fusion Protein FRSW117 - Severe Hemophilia A	Phase 3	Completed	Hangzhou Gensciences Biopharmaceutical Co., Ltd.	124	2023-12-27	2026-09-09
A Study Evaluating Physical Activity and Joint Health in Severe Haemophilia A Patients ≥12 Years Treated Once Weekly With Efanesoctocog Alfa Efanesoctocog alfa - Hemophilia A, Severe	Phase 3	Completed	Swedish Orphan Biovitrum	93	2023-07-31	2026-07-02
rFVIII-Fc (Produced by AryoGen Pharmed Co.) Pharmacokinetic Study Factor VIII, recombinant human with Fc fusion (rFVIII-Fc) - Severe Hemophilia A	Phase 3	Completed	AryoGen Pharmed Co.	50	2023-07-22	2023-11-18
A Research Study Looking at How Safe it is to Switch From Emicizumab to Mim8 in People With Haemophilia A (FRONTIER 5) NNC0365-3769 (Mim8) PPX - Haemophilia A, Haemophilia A With Inhibitors	Phase 3	Completed	Novo Nordisk A/S	61	2023-06-26	2025-12-08
A Study of Adynovate in Previously Treated Chinese Teenagers and Adults With Severe Hemophilia A Adynovate - Hemophilia A	Phase 3	Completed	Takeda	37	2023-03-27	2025-05-01
Caplacizumab and Immunosuppressive Therapy Without Firstline Therapeutic Plasma Exchange in Adults With Immune-mediated Thrombotic Thrombocytopenic Purpura Caplacizumab, Corticosteroids, anti-CD20 antibody - Thrombotic Thrombocytopenic Purpura	Phase 3	Completed	Sanofi	51	2022-11-21	2025-12-30
The Combination of ATRA and Eltrombopag as the Treatment of Steroid-resistant/Relapse ITP Based on MSC-C5b-9 all-trans retinoic acid, Eltrombopag - Purpura, Thrombocytopenic, Idiopathic	Phase 3	Completed	Peking University People's Hospital	96	2022-10-12	2025-09-09
Intravenous Immunoglobulin (IVIG, Bioven) Efficacy and Safety in Chronic Primary Immune Thrombocytopenia (ITP) in Adults Intravenous immunoglobulin (IVIG), 10% solution for infusion - Primary Immune Thrombocytopenia	Phase 3	Completed	Biopharma Plasma LLC	32	2022-07-26	2024-09-23
Evaluation of Avatrombopag for the Treatment of Thrombocytopenia in Japanese Adults With Chronic ITP Avatrombopag Oral Tablet - Immune Thrombocytopenia	Phase 3	Completed	Sobi, Inc.	19	2022-06-15	2026-06-03
A Research Study Investigating Nonacog Beta Pegol (N9-GP) for Treatment and Prevention of Bleedings in Chinese People With Haemophilia B Nonacog beta pegol - Haemophilia B	Phase 3	Completed	Novo Nordisk A/S	30	2022-05-18	2026-01-12
Study of the Safety and Immunogenicity of Long-term GNR-069 Therapy in ITP Patients GNR-069 - Idiopathic Thrombocytopenic Purpura	Phase 3	Completed	AO GENERIUM	160	2022-03-28	2024-06-21
A Study to Learn How Safe the Study Treatment BAY94-9027 is and How it Affects the Body in Previously Treated Children Aged 7 to Less Than 12 Years With Severe Hemophilia A, a Genetic Bleeding Disorder That is Caused by the Lack of a Protein Called Clotting Factor 8 (FVIII) in the Blood Damoctocog alfa pegol (Jivi, BAY94-9027) - Treatment of Bleeding, Prophylaxis of Bleeding	Phase 3	Completed	Bayer	36	2022-03-23	2026-07-02
Evaluation of Glucocorticoids Plus Rituximab in Patients With Newly-Diagnosed or Relapsing IgA Vasculitis Rituximab Injection, placebo - IgA Vasculitis	Phase 3	Completed	Hopital Foch	75	2022-03-11	2026-06-11
A Research Study Investigating Mim8 in Adults and Adolescents With Haemophilia A With or Without Inhibitors NNC0365-3769 (Mim8) - Haemophilia A, Haemophilia A With Inhibitors	Phase 3	Completed	Novo Nordisk A/S	281	2021-12-02	2025-12-08
Phase III Study on HMPL-523 for Treatment of ITP HMPL-523, Placebo - Primary Immune Thrombocytopenia (ITP)	Phase 3	Completed	Hutchmed	272	2021-10-27	2026-05-04
Efficacy and Safety of Turoctocog Alfa Pegol (N8-GP) for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Chinese Patients With Haemophilia A (pathfinder10) turoctocog alfa pegol (N8-GP) - Haemophilia A	Phase 3	Completed	Novo Nordisk A/S	36	2021-09-27	2026-01-06
Efficacy, PK, Immunogenicity and Safety of Wilate in Severe Von Willebrand Disease (VWD) Patients <6 Years of Age Wilate - Von Willebrand Disease	Phase 3	Completed	Octapharma	12	2021-09-22	2026-02-20
Comparative Study of Clinical Efficacy and Safety of GNR-069 and Nplate in Patients With ITP GNR-069, Nplate - Idiopathic Thrombocytopenic Purpura	Phase 3	Completed	AO GENERIUM	160	2021-09-09	2024-03-06

Blood Coagulation Disorders: Clinical Trials

261 trials for Blood Coagulation Disorders, newest first

ClinicalTrials Daily · Areas · Conditions · Drugs · Sponsors ·

By phase and status

Trials (filtered) newest first · largest first

Narrower conditions

Broader conditions

Interventions

Sponsors

Countries

Top investigators

Results publications

NIH funding